What was the rationale for the study by Widmer and colleagues comparing alcohol-based solutions containing povidone iodine (Polyvinylpyrrolidone-Iodine) or chlorhexidine gluconate (Chlorhexidine Gluconate) as preoperative antisepsis for cardiac or abdominal surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rationale for the Widmer Study Comparing Chlorhexidine and Povidone-Iodine

The primary rationale for the Widmer study was the controversy about whether the efficacy of chlorhexidine gluconate and povidone-iodine differs for the prevention of surgical site infections (SSIs).

Evidence Supporting the Controversy as the Primary Rationale

The controversy regarding the comparative efficacy of these two antiseptic agents has been well-documented in medical literature:

  • Multiple guidelines highlight the ongoing debate about which antiseptic agent is superior for preventing SSIs. The 2014 Anaesthesia guidelines note that "the most appropriate and safe antiseptic solution to use on the skin remains controversial" 1.

  • Several investigators have compared the antiseptic efficacy of chlorhexidine and povidone-iodine under various experimental conditions, with most studies suggesting chlorhexidine's superiority, but results have not been entirely consistent 1.

  • Prior to the Widmer study, there was conflicting evidence about which agent was more effective, with some studies showing benefits of chlorhexidine while others showed no significant difference between the agents 2.

Evidence from Different Surgical Specialties

The controversy is evident across multiple surgical specialties:

  • In liver surgery, guidelines from the Enhanced Recovery After Surgery (ERAS) Society noted that "skin preparation with chlorhexidine-alcoholic solution is associated with a lower rate of surgical site infections, compared to povidone-iodine solution" 1.

  • However, in clean-contaminated abdominal surgery, a 2017 randomized clinical trial found "no difference was detected between chlorhexidine gluconate and povidone-iodine antiseptics for prevention of SSI" 2.

  • For emergency laparotomy, guidelines recommend "preoperative skin antisepsis with alcohol-based solutions, or chlorhexidine for patients with an allergy to alcohol-based skin solutions" with a note that "chlorhexidine with alcohol is optimal" 1.

Importance of the Research Question

The Widmer study addressed this controversy by:

  • Conducting a large-scale, multicenter, cluster-randomized trial specifically designed to determine whether povidone-iodine in alcohol was noninferior to chlorhexidine gluconate in alcohol for preventing SSIs in cardiac and abdominal surgery 3.

  • Using a rigorous methodology with standardized disinfectants and skin application processes to provide definitive evidence on this clinically important question 3.

Implications for Clinical Practice

The findings of the Widmer study have significant implications:

  • The study found that povidone-iodine in alcohol was noninferior to chlorhexidine gluconate in alcohol in preventing SSIs after cardiac or abdominal surgery 3.

  • This challenges previous assumptions about chlorhexidine's superiority and provides clinicians with evidence that both agents can be effective when properly formulated with alcohol.

  • The results help resolve the controversy by demonstrating that either agent can be used effectively, which is particularly important given concerns about chlorhexidine neurotoxicity in certain contexts 1.

Common Pitfalls in Antiseptic Selection

When selecting preoperative antiseptic agents, clinicians should be aware of:

  • The formulation matters: alcohol-based solutions generally perform better than aqueous solutions for both agents 1.

  • Patient-specific factors such as allergies may influence selection (chlorhexidine is recommended for patients with iodine allergies, and povidone-iodine for those with chlorhexidine allergies) 4.

  • The type of surgery and potential for contamination should be considered when selecting an antiseptic agent.

The Widmer study provides valuable evidence to guide clinical decision-making in this important aspect of surgical care, addressing a genuine controversy in the field of surgical antisepsis.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Wound Care and Antisepsis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the preferred preoperative skin antisepsis agent for a patient with hypertension, type 2 diabetes mellitus, and colon adenocarcinoma undergoing colon resection to prevent surgical site infection (SSI)?
What was the rationale for the study by Widmer and colleagues comparing povidone iodine and chlorhexidine gluconate (antiseptics) for preventing surgical site infections (SSIs)?
What is the preferred preoperative antiseptic solution, 0.7% iodine (iodine) povacrylex in 74% isopropyl alcohol or 2% chlorhexidine (chlorhexidine) gluconate in 70% isopropyl alcohol, for surgical site infection prevention?
What is the most appropriate oral voriconazole (Voriconazole) dosing regimen for a patient with a complicated intra-abdominal infection caused by echinocandin- and fluconazole-resistant Candida glabrata, transitioning from intravenous (IV) to oral therapy?
What is the best treatment for Irritable Bowel Syndrome (IBS)?
What is the best course of action for a patient with a low posaconazole trough concentration of 0.4 mg/L after hematopoietic cell transplant?
What is the most appropriate oral antibiotic regimen for a patient with a purulent skin abscess due to methicillin-susceptible Staphylococcus aureus (MSSA) at the time of discharge?
When is therapeutic drug monitoring (TDM) appropriate for a patient switched to isavuconazole (isavuconazonium sulfate) due to acute kidney injury (Impaired renal function) while being treated for invasive pulmonary mucormycosis?
What are common supplements taken for Mast Cell Activation Syndrome (MCAS)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.